Clinical studies for Lantus, a new insulin preparation presented.

Sanofi-Aventis has developed a long acting insulin called Lantus (insulin glargine) made by the DNA recombinant technology, showing an efficient blood sugar control for most of Asian diabetic patients including Koreans, which was conformed to the earlier clinical results.

In the Spring conference of the Korea Society of Diabetolgy at Seoul Grand Hilton hotel from May 10 to 12 many study rep...